Area of research
Hematology · Oncology
Research interest
Research interests include Acute Myeloid Leukemia Research, CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research, and Food Allergy and Anaphylaxis Research.
Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia
Biomarkers of severity and threshold of allergic reactions during oral peanut challenges
Association of Staphylococcus aureus colonization with food allergy occurs independently of eczema severity
The MALT1 locus and peanut avoidance in the risk for peanut allergy
Outcomes of immunosuppression minimization and withdrawal early after liver transplantation
Prevalence and Impact of De Novo Donor‐Specific Antibodies During a Multicenter Immunosuppression Withdrawal Trial in Adult Liver Transplant Recipients
Allergen specificity of early peanut consumption and effect on development of allergic disease in the Learning Early About Peanut Allergy study cohort
Effect of Avoidance on Peanut Allergy after Early Peanut Consumption
Impact of peanut consumption in the LEAP Study: Feasibility, growth, and nutrition
An ectopically expressed serum miRNA signature is prognostic, diagnostic, and biologically related to liver allograft rejection
Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy
Type 1 diabetes immunotherapy using polyclonal regulatory T cells
Long-Term Follow-Up of the Edmonton Protocol of Islet Transplantation in the United States
Long-Term Results in Recipients of Combined HLA-Mismatched Kidney and Bone Marrow Transplantation Without Maintenance Immunosuppression
High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation for Relapsing-Remitting Multiple Sclerosis (HALT-MS)
Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial
Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial
Prophylactic use of sublingual allergen immunotherapy in high-risk children: A pilot study
Identifying infants at high risk of peanut allergy: The Learning Early About Peanut Allergy (LEAP) screening study